BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 20178811)

  • 1. Losartan attenuates chronic cigarette smoke exposure-induced pulmonary arterial hypertension in rats: possible involvement of angiotensin-converting enzyme-2.
    Han SX; He GM; Wang T; Chen L; Ning YY; Luo F; An J; Yang T; Dong JJ; Liao ZL; Xu D; Wen FQ
    Toxicol Appl Pharmacol; 2010 May; 245(1):100-7. PubMed ID: 20178811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of renin-angiotensin-aldosterone system (RAAS) in the lung of smoking-induced pulmonary arterial hypertension (PAH) rats.
    Yuan YM; Luo L; Guo Z; Yang M; Ye RS; Luo C
    J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):249-53. PubMed ID: 25795458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats.
    Li G; Liu Y; Zhu Y; Liu A; Xu Y; Li X; Li Z; Su J; Sun L
    Lung; 2013 Aug; 191(4):327-36. PubMed ID: 23652350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II type 1 receptor mediates pulmonary hypertension and right ventricular remodeling induced by inhaled nicotine.
    Fried ND; Morris TM; Whitehead A; Lazartigues E; Yue X; Gardner JD
    Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1526-H1534. PubMed ID: 33577434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnolol ameliorates pneumonectomy and monocrotaline-induced pulmonary arterial hypertension in rats through inhibition of angiotensin II and endothelin-1 expression.
    Chang H; Chang CY; Lee HJ; Chou CY; Chou TC
    Phytomedicine; 2018 Dec; 51():205-213. PubMed ID: 30466619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral delivery of Angiotensin-converting enzyme 2 and Angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension.
    Shenoy V; Kwon KC; Rathinasabapathy A; Lin S; Jin G; Song C; Shil P; Nair A; Qi Y; Li Q; Francis J; Katovich MJ; Daniell H; Raizada MK
    Hypertension; 2014 Dec; 64(6):1248-59. PubMed ID: 25225206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme 2 activation suppresses pulmonary vascular remodeling by inducing apoptosis through the Hippo signaling pathway in rats with pulmonary arterial hypertension.
    Yan D; Li G; Zhang Y; Liu Y
    Clin Exp Hypertens; 2019; 41(6):589-598. PubMed ID: 30806090
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of chymase in cigarette smoke-induced pulmonary artery remodeling and pulmonary hypertension in hamsters.
    Wang T; Han SX; Zhang SF; Ning YY; Chen L; Chen YJ; He GM; Xu D; An J; Yang T; Zhang XH; Wen FQ
    Respir Res; 2010 Mar; 11(1):36. PubMed ID: 20356378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme 2 activation ameliorates pulmonary endothelial dysfunction in rats with pulmonary arterial hypertension through mediating phosphorylation of endothelial nitric oxide synthase.
    Li G; Zhang H; Zhao L; Zhang Y; Yan D; Liu Y
    J Am Soc Hypertens; 2017 Dec; 11(12):842-852. PubMed ID: 29146157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the vasoprotective axis of the renin-angiotensin system: a novel strategic approach to pulmonary hypertensive therapy.
    Bradford CN; Ely DR; Raizada MK
    Curr Hypertens Rep; 2010 Aug; 12(4):212-9. PubMed ID: 20556668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cigarette smoke exposure induced pulmonary artery pressure increase through inhibiting Kv1.5 and Kv2.1 mRNA expression in rat pulmonary artery smooth muscles].
    Lin CY; Wan LM; Chen YQ; Ou HT; Zhao L; Liang YT; Ma R; Lu WJ; Wang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Sep; 35(9):695-9. PubMed ID: 23158075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implication of PDGF signaling in cigarette smoke-induced pulmonary arterial hypertension in rat.
    Xing AP; Hu XY; Shi YW; Du YC
    Inhal Toxicol; 2012 Jul; 24(8):468-75. PubMed ID: 22746397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats.
    Klimas J; Olvedy M; Ochodnicka-Mackovicova K; Kruzliak P; Cacanyiova S; Kristek F; Krenek P; Ochodnicky P
    J Cell Mol Med; 2015 Aug; 19(8):1965-74. PubMed ID: 25766467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of ACE2 prevents hypoxia-induced pulmonary hypertension in rats by inhibiting proliferation and immigration of PASMCs.
    Hu HH; Zhang RF; Dong LL; Chen EG; Ying KJ
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3968-3980. PubMed ID: 32329874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension.
    Morrell NW; Morris KG; Stenmark KR
    Am J Physiol; 1995 Oct; 269(4 Pt 2):H1186-94. PubMed ID: 7485548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of losartan on right ventricular hypertrophy and cardiac angiotensin I-converting enzyme activity in pulmonary hypertensive rats.
    Kreutz R; Fernandez-Alfonso MS; Ganten D; Paul M
    Clin Exp Hypertens; 1996 Jan; 18(1):101-11. PubMed ID: 8822237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system.
    Leenen FH; White R; Yuan B
    Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2410-6. PubMed ID: 11709406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II type 1 receptor-mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice.
    Xia H; Feng Y; Obr TD; Hickman PJ; Lazartigues E
    Hypertension; 2009 Feb; 53(2):210-6. PubMed ID: 19124678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension.
    Shenoy V; Ferreira AJ; Qi Y; Fraga-Silva RA; Díez-Freire C; Dooies A; Jun JY; Sriramula S; Mariappan N; Pourang D; Venugopal CS; Francis J; Reudelhuber T; Santos RA; Patel JM; Raizada MK; Katovich MJ
    Am J Respir Crit Care Med; 2010 Oct; 182(8):1065-72. PubMed ID: 20581171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension.
    Ferreira AJ; Shenoy V; Yamazato Y; Sriramula S; Francis J; Yuan L; Castellano RK; Ostrov DA; Oh SP; Katovich MJ; Raizada MK
    Am J Respir Crit Care Med; 2009 Jun; 179(11):1048-54. PubMed ID: 19246717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.